| __timestamp | Bristol-Myers Squibb Company | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 11947000000 | 1256834000000 |
| Thursday, January 1, 2015 | 12651000000 | 1271973000000 |
| Friday, January 1, 2016 | 14481000000 | 1173296000000 |
| Sunday, January 1, 2017 | 14710000000 | 1274610000000 |
| Monday, January 1, 2018 | 16014000000 | 1437534000000 |
| Tuesday, January 1, 2019 | 18067000000 | 2201424000000 |
| Wednesday, January 1, 2020 | 30745000000 | 2203504000000 |
| Friday, January 1, 2021 | 36445000000 | 2462160000000 |
| Saturday, January 1, 2022 | 36022000000 | 2783406000000 |
| Sunday, January 1, 2023 | 34313000000 | 2832257000000 |
| Monday, January 1, 2024 | 36351000000 | 2832257000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. This analysis delves into the gross profit trajectories of two giants: Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited, from 2014 to 2023. Over this period, Takeda's gross profit consistently outpaced Bristol-Myers Squibb, with Takeda's profits peaking at approximately 2.83 trillion in 2023, marking a 125% increase from 2014. In contrast, Bristol-Myers Squibb saw a significant rise in 2020, with profits reaching 3.07 billion, a 157% increase from 2014, before stabilizing around 3.43 billion in 2023. Notably, 2024 data for Bristol-Myers Squibb is missing, highlighting potential data gaps. This financial journey underscores the dynamic nature of the pharmaceutical sector, where strategic decisions and market conditions shape fiscal outcomes.
Who Generates Higher Gross Profit? Novartis AG or Bristol-Myers Squibb Company
Gross Profit Analysis: Comparing Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Regeneron Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Viatris Inc.
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Bristol-Myers Squibb Company and Perrigo Company plc: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs HUTCHMED (China) Limited
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Takeda Pharmaceutical Company Limited Trends
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs Genmab A/S
Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Vericel Corporation: A Gross Profit Performance Breakdown
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends